Cutaneous cellular fibrous histiocytoma metastasizing to the lungs [3]

Histopathology

Volumn 41, Issue 1, 2002, Pages 85-86

  De Hertogh, G ^a   Bergmans, G ^b   Molderez, C ^b   Sciot, R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Department of Pathology ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; TUMOR MARKER;

ADULT; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; DERMATOFIBROMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LUNG METASTASIS; MALE; MITOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR CELL; BACK; LUNG TUMOR; METABOLISM; METASTASIS; MITOSIS INDEX; PATHOLOGY; SKIN TUMOR;

ADULT; BACK; CASE REPORT; HISTIOCYTOMA, FIBROUS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MITOTIC INDEX; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS;

EID: 0035985623     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.t01-1-01368.x     Document Type: Letter

References (7)

1. Cellular benign fibrous histiocytoma. Clinicopathological analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence
2. Metastasizing cellular dermatofibroma. A report of two cases
3. Metastasizing dermatofibroma
4. Multiple cystic fibrohistiocytic tumors of the lung: A report of two cases
5. Metastasizing fibrous histiocytoma of the skin: A clinicopathologic and immunohistochemical analysis of three cases
6. Is cutaneous benign fibrous histiocytoma (dermatofibroma) a reactive inflammatory process or a neoplasm?
7. Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: A report of the CHAMP Study Group